United States · Series A startup

Who invested in Eyebiotech

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$65Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $65MNov 2023
Investors
5
See who backed them

The rounds

  1. Nov 2023

Founders and team

From the SEC filings it signed: 2 on the team.

  • David Robert GuyerExecutive Officeri
  • Michael Jay RossExecutive Officeri

On the board, as filediCatherine Elizabeth BinghamJames Allister John Costine

Everyone who backed them

Vertex VenturesVC firm1round
Omega FundsVC firm1round
Samsara BioCapitalVC firm1round
SV Health InvestorsVC firm1round
Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Eyebiotech

Who invested in Eyebiotech?

Eyebiotech's investors include Vertex Ventures, Omega Funds, Samsara BioCapital, SV Health Investors and Bain Capital Life Sciences.

How much has Eyebiotech raised?

Eyebiotech has raised $65M across 1 round since 2023.

When did Eyebiotech last raise?

Eyebiotech's most recent round was a Series A of $65M in Nov 2023.

What was Eyebiotech's biggest round?

Its most recent round, $65M in Nov 2023, is also its largest on record.

Who backed Eyebiotech first?

Eyebiotech's first round on record, in Nov 2023, was backed by Vertex Ventures, Omega Funds and Samsara BioCapital and 2 others.

What stage is Eyebiotech at?

Eyebiotech's latest named round is a Series A, in Nov 2023.

Where is Eyebiotech based?

Eyebiotech is based in the United States.

Companies like Eyebiotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.